Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 24,272 | 0 | 25,096 | 19,136 |
| Cost of Goods | 9,786 | N/A | 9,480 | 10,866 |
| Gross Profit | 14,486 | N/A | 15,616 | 8,270 |
| Operating Expenses | 14,140 | 0 | 9,385 | 9,354 |
| Operating Income | 1,132 | N/A | 6,711 | -218 |
| Interest Expense | 375 | 0 | 2 | 1 |
| Other Income | -605 | 0 | 188 | 411 |
| Pre-tax Income | 152 | 0 | 6,897 | 192 |
| Income Tax | 50 | N/A | 357 | -7,919 |
| Net Income Continuous | 102 | N/A | 6,540 | 8,111 |
| Net Income | $102 | $N/A | $6,540 | $8,111 |
| EPS Basic Total Ops | N/A | N/A | 0.05 | 0.07 |
| EPS Basic Continuous Ops | 0.00 | N/A | 0.23 | 0.28 |
| EPS Diluted Total Ops | N/A | N/A | 0.05 | 0.06 |
| EPS Diluted Continuous Ops | 0.00 | N/A | 0.21 | 0.26 |
| EBITDA(a) | $1,299 | $N/A | $6,890 | $-218 |